Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for chest pain in coronary slow flow
IRCT20210711051842N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pentoxifylline in Slow Coronary Flow (SCF), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Severity of chest pain based on Likert scale, Frequency of chest pain and 1 more. Started Apr 2022; status: completed.
02
Drugs
pentoxifylline
03
Conditions
Slow Coronary Flow (SCF)
Beyond the preview
Go deeper on IRCT20210711051842N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210711051842N1.